Abstract
The report covers a forecast and an analysis of the embolization particle market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based revenue (USD Million). The study includes drivers and restraints for the embolization particle market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the embolization particle market on a global level.
In order to give the users of this report a comprehensive view of the embolization particle market, we have included a competitive landscape and an analysis of Porter’s Five Forces model of the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments in the market, including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.
The study provides a decisive view of the embolization particle market by segmenting the market based on particle type, application, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024.
Based on particles type, the embolization particle market is segmented into microspheres, particles, drug-eluting beads (DEBs), and radio-embolic microspheres. Based on application, the embolization particle market is segmented into trauma embolization, liver tumor embolization, prostatic artery embolization, uterine fibroid embolization, and others.
The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further bifurcation into major countries, including the U.S., Germany, France, UK, China, Japan, India, and Brazil.
Some major players of the embolization particle market include Sirtex Medical Limited, Boston Scientific Corporation, Merit Medical Systems, BTG International Ltd., Cook Medical, and Interface BIOmaterials, among others.
This report segments the global embolization particle market as follows:
Global Embolization Particle Market: Particle Type Analysis
Microspheres
Particles
Drug-Eluting Beads (DEBs)
Radio-Embolic Microspheres
Global Embolization Particle Market: Application Analysis
Trauma Embolization
Liver Tumor Embolization
Prostatic Artery Embolization
Uterine Fibroid Embolization
Others
Global Embolization Particle Market: Regional Analysis
North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa